Dietary compliance in celiac disease

作者：Freeman Hugh James

来源：World Journal of Gastroenterology, 2017, 23(15): 2635-2639.

DOI：10.3748/wjg.v23.i15.2635

• Gluten-free diet
• Compliance
• Dietary recall
• Celiac disease
• Fecal immunoreactive peptides
• Tissue transglutaminase antibodies

resolution of diarrhea, weight gain and normalization of nutrient malabsorption. In addition, histopathological changes also normalize, but this histopathological response appears to be time-dependent, sex-dependent and age-dependent. Compliance to a gluten-free diet is difficult and costly resulting in poor compliance and only a limited clinical response. This poses a risk for later long-term complications, including malignancy. A major practical clinical problem is the assessment of compliance to the gluten-free diet. Although symptoms may resolve and serological antibody markers may improve, multiple studies have documented ongoing architectural disturbance and inflammatory change, and with these continued inflammatory changes, a persistent risk for long-term complications. Recent immunological studies have suggested that peptides can be detected in both urine and fecal specimens that may be indicative of limited compliance. At the same time, multiple biopsy studies have demonstrated that complete normalization of the mucosa may occur in some patients within 6 mo of initiation of a glutenfree diet, but more often, up to 2 years or more may be required before repeated biopsies eventually show mucosal recovery and mucosal healing. Celiac disease is an immune-mediated disorder that causes severe architectural disturbance in the small intestinal mucosa of genetically-predisposed individuals. Impaired absorption of multiple nutrients results and diarrhea and weight loss develop. Evidence has accumulated that a strict gluten-free diet can result in

• 出版日期2017-4-21